This site is intended for healthcare professionals only
LoginRegister
Emcures Poviztra Cleared for Fatty Liver Treatment Following CDSCO Nod to WegovyEmcure's Poviztra Cleared for Fatty Liver Treatment Following CDSCO Nod to Wegovy
Lupin Transfers Two Cancer Drug Programmes to Kaveri Therapeutics, Acquires 82.2% StakeLupin Transfers Two Cancer Drug Programmes to Kaveri Therapeutics, Acquires 82.2% Stake
AstraZeneca Pharma India CFO Bhavana Agrawal Steps DownAstraZeneca Pharma India CFO Bhavana Agrawal Steps Down
USFDA Approves Expanded Pediatric Use of Glenmarks RYALTRIS Nasal SprayUSFDA Approves Expanded Pediatric Use of Glenmark's RYALTRIS Nasal Spray
Aspens Generic Ozempic Gets Health Canada ApprovalAspen's Generic Ozempic Gets Health Canada Approval, Launch Hinges on Dr Reddy's API Supply
India Gets Its First Dengue Vaccine as DCGI Approves Takedas QDENGAIndia Gets Its First Dengue Vaccine as DCGI Approves Takeda's QDENGA
MSD Pharma Gets Conditional SEC Approval to Begin Phase III Trial of Sacituzumab TirumotecanMSD Receives CDSCO Panel Nod to Conduct Phase III Trial of Enlicitide Decanoate
Alembic, NATCO Receive USFDA Tentative Approval for Generic Cancer Drug OlaparibAlembic, NATCO Receive USFDA Tentative Approval for Generic Cancer Drug Olaparib
SC Steps In Over Affordable Access to Patented Cancer Drugs, Seeks Expeditious HearingSC Steps In Over Affordable Access to Patented Cancer Drugs, Seeks Expeditious Hearing
Kerala Health Minister Calls for Probe, Workload Reforms After Medical Representatives Alleged SuicideKerala Health Minister Calls for Probe, Workload Reforms After Medical Representative's Alleged...
Bogus Medicine Factory Using Reputed Pharma Brands Busted in UttarakhandBogus Medicine Factory Using Reputed Pharma Brands Busted in Uttarakhand
Merck India Collaborates with NMIMS for Global Pharma Capability Training ProgramMerck India Collaborates with NMIMS for Global Pharma Capability Training Program
X